<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="162960">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01693796</url>
  </required_header>
  <id_info>
    <org_study_id>2010-A01118-31</org_study_id>
    <secondary_id>2010-09</secondary_id>
    <nct_id>NCT01693796</nct_id>
  </id_info>
  <brief_title>Evaluation of Thyroid Exposure to Radiation Doses During Paediatric Cardiac Catheterisations Performed for Diagnosis or the Treatment of Congenital Heart Disease</brief_title>
  <official_title>Evaluation of Thyroid Exposure to Radiation Doses During Paediatric Cardiac Catheterisations Performed for Diagnosis or the Treatment of Congenital Heart Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <authority>France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the average risk for thyroid irradiation for any
      type of paediatric cardiac catheterization, based on the cummulative at-risk dose of  100
      mSv, adjusted to the measured thyroid volume and to the patient's age.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">April 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>exposure to radiation measure</measure>
    <time_frame>2 YEARS</time_frame>
    <safety_issue>No</safety_issue>
    <description>To determine the average risk for thyroid irradiation for any type of paediatric cardiac catheterization, based on the cummulative at-risk dose of  100 mSv, adjusted to the measured thyroid volume and to the patient's age.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>exposure to radiation measure</measure>
    <time_frame>2 YEARS</time_frame>
    <safety_issue>No</safety_issue>
    <description>Fit the dose of average irradiation of the thyroid during the catheterizations to the thyroïdien volume</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Cardiac Catheterizations</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>blood and urine samples ; Echography</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Inclusion of any patient (&lt; 18 year-old) with congenital heart disease undergoing one
             or more cardiac catheterization

        Exclusion Criteria:

          -  Exclusion of patients with any type of thyroid dissease
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>BERNARD BELAIGUES</last_name>
    <role>Study Chair</role>
    <affiliation>Assistance Publique hôpitaux de Marseille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>alain fraisse</last_name>
    <email>alain.fraisse@ap-hm.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assistance Publique Hopitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13354</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>alain FRAISSE</last_name>
      <email>alain.fraisse@ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>alain fraisse</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <lastchanged_date>September 24, 2012</lastchanged_date>
  <firstreceived_date>April 5, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
